MARKET

ICU

ICU

SeaStar Medical Holding Corp
NASDAQ
1.900
-0.060
-3.06%
Pre Market: 1.940 +0.04 +2.11% 07:38 11/11 EST
OPEN
1.960
PREV CLOSE
1.960
HIGH
1.969
LOW
1.900
VOLUME
668
TURNOVER
0
52 WEEK HIGH
5.38
52 WEEK LOW
1.840
MARKET CAP
8.37M
P/E (TTM)
-0.4840
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ICU last week (1102-1106)?
Weekly Report · 2d ago
SeaStar Medical Holding Corporation Announces FDA Determination on QUELIMMUNE Post-Approval Study Requirements on November 3, 2026
NASDAQ · 11/03 20:00
FDA Confirms SeaStar Medical Meets QUELIMMUNE Post-Approval Study Requirements
NASDAQ · 11/03 18:20
FDA Clears QUELIMMUNE Study Requirements, Expanding Pediatric Access
TipRanks · 11/03 14:28
SeaStar Medical Announces FDA Determines QUELIMMUNE Pediatric SAVE Registry Has Fulfilled Post-Approval Study Requirements
Benzinga · 11/03 13:22
Weekly Report: what happened at ICU last week (1026-1030)?
Weekly Report · 11/02 09:57
SeaStar Medical registers to sell 1.77M shares of common stock for holders
TipRanks · 10/30 20:15
SeaStar Medical Files Prospectus For Offering 1.768M Common Shares On Behalf Of Selling Shareholders
Benzinga · 10/30 20:13
More
About ICU
SeaStar Medical Holding Corporation is a commercial-stage medical technology company, which is focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. It has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).

Webull offers SeaStar Medical Holding Corp stock information, including NASDAQ: ICU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICU stock methods without spending real money on the virtual paper trading platform.